Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Seizures × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 146 Breast Neoplasms 87 Colorectal Neoplasms 63 Neoplasms 53 Pancreatic Neoplasms 51 Lung Neoplasms 48 Neoplasm Metastasis 45 Ovarian Neoplasms 42 Stomach Neoplasms 41 Rectal Neoplasms 41 Esophageal Squamous Cell Carcinoma 34 Esophageal Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 30 Head and Neck Neoplasms 30 Leukemia, Myeloid, Acute 27 Recurrence 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Triple Negative Breast Neoplasms 21 Small Cell Lung Carcinoma 20 Nasopharyngeal Carcinoma 20 Glioblastoma 20 Uterine Cervical Neoplasms 19 Fallopian Tube Neoplasms 19 Lymphoma, Non-Hodgkin 18 Lymphoma 18 Colonic Neoplasms 17 Prostatic Neoplasms 16 Leukemia 15 Carcinoma, Ovarian Epithelial 15 Melanoma 14

Interventions

Levetiracetam 6 Cannabidiol 4 perampanel 2 Standard of Care 2 Everolimus 2 enzalutamide 1 Vigabatrin 1 Tranexamic Acid 1 Temozolomide 1 Sodium Chloride 1 Saline Solution 1 Pregabalin 1 Medical Marijuana 1 Magnesium Sulfate 1 Drug Therapy 1 Curcumin 1 Cholecalciferol 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1 Airway Extubation 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04450160 2020-06-29

AEO

MetVital, Inc.

Phase 2 Unknown

Glioblastoma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡